Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group.

Kudoh, S; Fujiwara, Y; Takada, Y; Yamamoto, H; Kinoshita, A; Ariyoshi, Y; Furuse, K; Fukuoka, M

Kudoh, S; Fujiwara, Y; Takada, Y; Yamamoto, H; Kinoshita, A; Ariyoshi, Y; Furuse, K; Fukuoka, M.

Affiliation

Kudoh S; First Department of Internal Medicine, Osaka City University Medical School, Osaka, Japan. shinzohykudoh@msic.med.osaka-cu.ac.jp

J Clin Oncol ; 16(3): 1068-74, 1998 Mar.

Article in En | MEDLINE | ID: mdl-9508192

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Small Cell/drug therapy; Lung Neoplasms/drug therapy; Adult; Aged; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Carcinoma, Small Cell/radiotherapy; Cisplatin/administration & dosage; Combined Modality Therapy; Female; Humans; Irinotecan; Lung Neoplasms/radiotherapy; Male; Middle Aged; Salvage Therapy; Survival Analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Small Cell / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1998 Type: Article Affiliation country: Japan

Search on Google

XML

PubMed Links